| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000009575 |
| Receipt No. | R000011233 |
| Official scientific title of the study | Efficacy and safety analysis of monthly minodronic acid in Japanese osteoporotic patients switched from traditional bisphosphonates |
| Date of disclosure of the study information | 2012/12/18 |
| Last modified on | 2018/03/08 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Efficacy and safety analysis of monthly minodronic acid in Japanese osteoporotic patients switched from traditional bisphosphonates | |
| Title of the study (Brief title) | Usefulness of switching to monthly minodronic acid in Japanese osteoporotic patients | |
| Region |
|
|
| Condition | ||||||||||
| Condition | Osteoporosis | |||||||||
| Classification by specialty |
|
|||||||||
| Classification by malignancy | Others | |||||||||
| Genomic information | NO | |||||||||
| Objectives | |
| Narrative objectives1 | To investigate the usefulness of switching to
monthly minodronic acid in Japanese osteoporotic patients who were taking traditional bisphosphonates (BPs). –Six months intervention study |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Bone mineral density
Bone turnover marker |
| Key secondary outcomes | Low back pain
Abdominal symptoms Preference and adherence for BPs Osteoporotic fracture |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Minodronic acid (50mg/month)
|
|
| Interventions/Control_2 | Another BPs | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Patients with osteoporosis
2. Patients who were taking traditional BPs 3. Patients giving informed consent |
|||
| Key exclusion criteria | Patients with
1. Esophageal stricture or achalasia 2. Incapability in remaining upright for 30 min 3.Hypersensitivity to minodronic acid and other bisphosphonates 4. Hypocalcemia 5. Pregnancy 6. Aphagia, Esophagitis, Gastritis, Duodenitis or Ulcers 7. Severe renal dysfunction |
|||
| Target sample size | 600 | |||
| Research contact person | |
| Name of lead principal investigator | Satoshi Ikeda |
| Organization | Ken-Ai Memorial Hospital |
| Division name | Department of Orthopedic Surgery |
| Address | 1191 Oaza Kimori, Onga-Machi, Onga-Gun Fukuoka, 811-4313 Japan |
| TEL | 093-293-7090 |
| Public contact | |
| Name of contact person | |
| Organization | Ken-Ai Memorial Hospital |
| Division name | Department of Orthopedic Surgery |
| Address | |
| TEL | |
| Homepage URL | |
| s-ikeda@med.uoeh-u.ac.jp | |
| Sponsor | |
| Institute | Ken-Ai Memorial Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Astellas Pharma Inc. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | Sanzai Hospital
Tsurukami Orthopaedic and Rheumatoid Clinic Kitakyushu General Hospital Makiyama Chuou Hospital Obase Hospital Katsuki Neurosurgery and Orthopaedic Clinic |
| Name of secondary funder(s) |
Teshima Orthopaedic Clinic Okimoto Clinic Sakamidorii Hospital Okamoto Orthopaedic Clinic |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000011233 |